Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
T-Mobile US
TMUS
$191B
| $365M | 0.12% |
2,855,760
+55,900
| +2% | +$7.79M |
|
152
Sherwin-Williams
SHW
$88.1B
| $363M | 0.12% |
1,297,849
+32,956
| +3% | +$9.65M |
|
153
SBA Communications
SBAC
$19.2B
| $360M | 0.12% |
1,087,651
+41,850
| +4% | +$14.5M |
|
154
Fidelity National Information Services
FIS
$21.9B
| $356M | 0.12% |
2,929,535
+246,405
| +9% | +$33M |
|
155
Tyson Foods
TSN
$20.1B
| $355M | 0.12% |
4,496,424
+172,745
| +4% | +$13M |
|
156
Chubb
CB
$134B
| $353M | 0.12% |
2,035,497
-25,577
| -1% | -$4.48M |
|
157
Best Buy
BBY
$17.4B
| $352M | 0.12% |
3,333,808
+217,101
| +7% | +$24.4M |
|
158
Cigna
CI
$73.6B
| $350M | 0.11% |
1,749,235
+28,417
| +2% | +$6.18M |
|
|
MRSH
159
Marsh
MRSH
$91B
| $347M | 0.11% |
2,290,219
+15,656
| +0.7% | +$2.37M |
|
160
Schwab US REIT ETF
SCHH
$11.2B
| $345M | 0.11% |
15,108,512
+170,924
| +1% | +$4.08M |
|
161
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
| $341M | 0.11% |
6,401,297
+164,028
| +3% | +$8.77M |
|
162
Novartis
NVS
$298B
| $337M | 0.11% |
4,116,468
+38,337
| +0.9% | +$3.45M |
|
163
Estee Lauder
EL
$31.5B
| $333M | 0.11% |
1,109,841
+18,414
| +2% | +$6.02M |
|
164
Edwards Lifesciences
EW
$53B
| $333M | 0.11% |
2,938,697
+59,772
| +2% | +$6.82M |
|
165
International Paper
IP
$21.9B
| $325M | 0.11% |
6,146,701
+462,535
| +8% | +$25.7M |
|
166
Regions Financial
RF
$26.8B
| $325M | 0.11% |
15,262,774
+1,659,459
| +12% | +$33M |
|
167
Northern Trust
NTRS
$34.4B
| $323M | 0.11% |
2,997,478
+252,168
| +9% | +$28.6M |
|
168
Welltower
WELL
$169B
| $322M | 0.11% |
3,912,469
+115,586
| +3% | +$9.93M |
|
169
Ford
F
$55.8B
| $321M | 0.11% |
22,690,507
-794,334
| -3% | -$10.8M |
|
170
Regeneron Pharmaceuticals
REGN
$83.2B
| $320M | 0.1% |
529,528
+24,645
| +5% | +$15.3M |
|
171
Arthur J. Gallagher & Co
AJG
$64.7B
| $320M | 0.1% |
2,153,408
+4,511
| +0.2% | +$645K |
|
172
Boston Scientific
BSX
$73.1B
| $319M | 0.1% |
7,359,880
+709,180
| +11% | +$31.4M |
|
173
Fidelity MSCI Health Care Index ETF
FHLC
$3.42B
| $316M | 0.1% |
4,950,295
+58,473
| +1% | +$3.86M |
|
174
CSX Corp
CSX
$92.8B
| $313M | 0.1% |
10,534,592
+68,641
| +0.7% | +$2.2M |
|
175
Southern Company
SO
$105B
| $313M | 0.1% |
5,047,029
+80,550
| +2% | +$5.19M |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.